Immunotherapy refers to treatment that uses a person’s immune system to fight diseases, namely cancer. Immunotherapies have been changing how we fight cancer at a foundational level by first stimulating the body’s own defense system unlike other conventional treatment options including surgery, radiation, and chemotherapy. Immunotherapy can work in several ways, from boosting your immune system overall to targeting specific types of cells. Some of the most common types of treatment include:
- Targeted antibodes
- T-Cell theraphy
- Cancer vaccines.
There are many studies investigating the various pros and cons to new immunotherapy drugs, and as more and more have been approved for treatment by the FDA, the pace of developing new, more targeted ones, has only accelerated in recent years. Advances in Biotechnology and increased M&A activity in the Healthcare sector has garnered the attention of investors, especially those seeking out high-growth opportunities with disruptive potential.
Click on the tabs below to see more information on Immunotherapy ETFs, including historical performance, dividends, holdings, expense ratios, technical indicators, analysts reports and more. Click on an ETF ticker or name to go to its detail page, for in-depth news, financial data and graphs. By default the list is ordered by descending total market capitalization.
As of 10/14/19